EGFR-dependent migration of glial cells is mediated by reorganisation of N-cadherin

Journal of Cell Science

Volumn 121, Issue 24, 2008, Pages 4089-4097

  Rappl, Anne ^a   Piontek, Guido ^b   Schlegel, Jürgen ^a,b  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

Adhesion; Cell morphology; Signal transduction

Indexed keywords

6 [4 (4 ETHYL 1 PIPERAZINYLMETHYL)PHENYL] 4 (ALPHA METHYLBENZYLAMINO) 7H PYRROLO[2,3 D]PYRIMIDINE; BETA CATENIN; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; HETERODIMER; NERVE CELL ADHESION MOLECULE; PROTEIN TYROSINE KINASE INHIBITOR; TYROSINE;

ARTICLE; CANCER CELL CULTURE; CELL MEMBRANE; CELL MIGRATION; CELL STRUCTURE; COMPLEX FORMATION; CONTROLLED STUDY; DOWN REGULATION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; GLIOMA CELL; HUMAN; HUMAN CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; RECEPTOR BLOCKING; RNA INTERFERENCE; SIGNAL TRANSDUCTION; UPREGULATION;

BETA CATENIN; CADHERINS; CELL LINE, TUMOR; CELL MOVEMENT; DOWN-REGULATION; HUMANS; NEUROGLIA; PHOSPHORYLATION; PURINES; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 59349097033     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: 10.1242/jcs.027995     Document Type: Article

References (39)

1. Andersson, U., Guo, D., Malmer, B., Bergenheim, A. T., Brannstrom, T., Hedman, H. and Henriksson, R. (2004). Epidermal growth factor receptor family (EGFR, ErbB2-4) in gliomas and meningiomas. Acta Neuropathol. 108, 135-142.
2. Angst, B. D., Marcozzi, C. and Magee, A. I. (2001). The cadherin superfamily: diversity in form and function. J. Cell Sci. 114, 629-641.
3. Asano, K., Kubo, O., Tajika, Y., Takakura, K. and Suzuki, S. (2000). Expression of cadherin and CSF dissemination in malignant astrocytic tumours. Neurosurg. Rev. 23, 39-44.
4. Asano, K., Duntsch, C. D., Zhou, Q., Weimar, J. D., Bordelon, D., Robertson, J. H. and Pourmotabbed, T. (2004). Correlation of N-cadherin expression in high grade gliomas with tissue invasion. J. Neurooncol. 70, 3-15.
5. Barami, K., Lewis-Tuffin, L. and Anastasiadis, P. Z. (2006). The role of cadherins and catenins in gliomagenesis. Neurosurg. Focus 21, E13.
6. Birchmeier, W. and Behrens, J. (1994). Cadherin expression in carcinomas: role in the formation of cell junctions and the prevention of invasiveness. Biochim. Biophys. Acta 1198, 11-26.
7. Bowers, G., Reardon, D., Hewitt, T., Dent, P., Mikkelsen, R. B., Valerie, K., Lammering, G., Amir, C. and Schmidt-Ullrich, R. K. (2001). The relative role of ErbB1-4 receptor tyrosine kinases in radiation signal transduction responses of human carcinoma cells. Oncogene 20, 1388-1397.
8. Brazil, D. P., Yang, Z. Z. and Hemmings, B. A. (2004). Advances in protein kinase B signalling: AKTion on multiple fronts. Trends Biochem. Sci. 29, 233-242.
9. Cantley, L. C. (2002). The phosphoinositide 3-kinase pathway. Science 296, 1655-1657.
10. Cavallaro, U. and Christofori, G. (2004). Cell adhesion and signalling by cadherins and Ig-CAMs in cancer. Nat. Rev. Cancer 4, 118-132.
11. Demuth, T. and Berens, M. E. (2004). Molecular mechanisms of glioma cell migration and invasion. J. Neurooncol. 70, 217-228.
12. Derycke, L. D. and Bracke, M. E. (2004). N-cadherin in the spotlight of cell-cell adhesion, differentiation, embryogenesis, invasion and signalling. Int. J. Dev. Biol. 48, 463-476.
13. Dietzmann, K. and von Bossanyi, P. (1994). Coexpression of epidermal growth factor receptor protein and c-erbB-2 oncoprotein in human astrocytic tumours. An immunohistochemical study. Zentralbl. Pathol. 140, 335-341.
14. Diserens, A. C., de Tribolet, N., Martin-Achard, A., Gaide, A. C., Schnegg, J. F. and Carrel, S. (1981). Characterization of an established human malignant glioma cell line: LN-18. Acta Neuropathol. 53, 21-28.
15. Dittmar, T., Husemann, A., Schewe, Y., Nofer, J. R., Niggemann, B., Zanker, K. S. and Brandt, B. H. (2002). Induction of cancer cell migration by epidermal growth factor is initiated by specific phosphorylation of tyrosine 1248 of c-erbB-2 receptor via EGFR. FASEB J. 16, 1823-1825.
16. Fang, D., Hawke, D., Zheng, Y., Xia, Y., Meisenhelder, J., Nika, H., Mills, G. B., Kobayashi, R., Hunter, T. and Lu, Z. (2007). Phosphorylation of beta-catenin by AKT promotes beta-catenin transcriptional activity. J. Biol. Chem. 282, 11221-11229.
17. Holbro, T. and Hynes, N. E. (2004). ErbB receptors: directing key signaling networks throughout life. Annu. Rev. Pharmacol. Toxicol. 44, 195-217.
18. Holbro, T., Civenni, G. and Hynes, N. E. (2003). The ErbB receptors and their role in cancer progression. Exp. Cell Res. 284, 99-110.
19. Hoschuetzky, H., Aberle, H. and Kemler, R. (1994). Beta-catenin mediates the interaction of the cadherin-catenin complex with epidermal growth factor receptor. J. Cell Biol. 127, 1375-1380.
20. Ishii, N., Maier, D., Merlo, A., Tada, M., Sawamura, Y., Diserens, A. C. and Van Meir, E. G. (1999). Frequent co-alterations of TP53, p16/ CDKN2A, p14ARF, PTEN tumor suppressor genes in human glioma cell lines. Brain Pathol. 9, 469-479.
21. Jorissen, R. N., Walker, F., Pouliot, N., Garrett, T. P., Ward, C. W. and Burgess, A. W. (2003). Epidermal growth factor receptor: mechanisms of activation and signalling. Exp. Cell Res. 284, 31-53.
22. Koka, V., Potti, A., Forseen, S. E., Pervez, H., Fraiman, G. N., Koch, M. and Levitt, R. (2003). Role of Her-2/neu overexpression and clinical determinants of early mortality in glioblastoma multiforme. Am. J. Clin. Oncol. 26, 332-335.
23. Lilien, J. and Balsamo, J. (2005). The regulation of cadherin-mediated adhesion by tyrosine phosphorylation/dephosphorylation of beta-catenin. Curr. Opin. Cell Biol. 17, 459-465.
24. Louis, D. N. (2006). Molecular pathology of malignant gliomas. Annu. Rev. Pathol. 1, 97-117.
25. Lu, Z., Ghosh, S., Wang, Z. and Hunter, T. (2003). Downregulation of caveolin-1 function by EGF leads to the loss of E-cadherin, increased transcriptional activity of beta-catenin, and enhanced tumor cell invasion. Cancer Cell 4, 499-515.
26. Messerle, K., Schlegel, J., Hynes, N. E. and Groner, B. (1994). NIH/3T3 cells transformed with the activated erbB-2 oncogene can be phenotypically reverted by a kinase deficient, dominant negative erbB-2 variant. Mol. Cell. Endocrinol. 105, 1-10.
27. Mineo, J. F., Bordron, A., Baroncini, M., Maurage, C. A., Ramirez, C., Siminski, R. M., Berthou, C. and Dam Hieu, P. (2007). Low HER2-expressing glioblastomas are more often secondary to anaplastic transformation of low-grade glioma. J. Neurooncol. 85, 281-287.
28. Osherov, N., Gazit, A., Gilon, C. and Levitzki, A. (1993). Selective inhibition of the epidermal growth factor and HER2/neu receptors by tyrphostins. J. Biol. Chem. 268, 11134-11142.
29. Perego, C., Vanoni, C., Massari, S., Raimondi, A., Pola, S., Cattaneo, M. G., Francolini, M., Vicentini, L. M. and Pietrini, G. (2002). Invasive behaviour of glioblastoma cell lines is associated with altered organisation of the cadherin-catenin adhesion system. J. Cell Sci. 115, 3331-3340.
30. Potti, A., Forseen, S. E., Koka, V. K., Pervez, H., Koch, M., Fraiman, G., Mehdi, S. A. and Levitt, R. (2004). Determination of HER-2/neu overexpression and clinical predictors of survival in a cohort of 347 patients with primary malignant brain tumours. Cancer Invest. 22, 537-544.
31. Schlegel, J., Stumm, G., Brandle, K., Merdes, A., Mechtersheimer, G., Hynes, N. E. and Kiessling, M. (1994). Amplification and differential expression of members of the erbB-gene family in human glioblastoma. J. Neurooncol. 22, 201-207.
32. Schlegel, J., Piontek, G., Budde, B., Neff, F. and Kraus, A. (2000). The Akt/protein kinase B-dependent anti-apoptotic pathway and the mitogen-activated protein kinase cascade are alternatively activated in human glioblastoma multiforme. Cancer Lett. 158, 103-108.
33. Schwechheimer, K., Zhou, L. and Birchmeier, W. (1998). E-Cadherin in human brain tumours: loss of immunoreactivity in malignant meningiomas. Virchows Arch. 432, 163-167.
34. Shinoura, N., Paradies, N. E., Warnick, R. E., Chen, H., Larson, J. J., Tew, J. J., Simon, M., Lynch, R. A., Kanai, Y., Hirohashi, S. et al. (1995). Expression of N-cadherin and alpha-catenin in astrocytomas and glioblastomas. Br. J. Cancer 72, 627-633.
35. Thomas, C. Y., Chouinard, M., Cox, M., Parsons, S., Stallings-Mann, M., Garcia, R., Jove, R. and Wharen, R. (2003). Spontaneous activation and signaling by overexpressed epidermal growth factor receptors in glioblastoma cells. Int. J. Cancer 104, 19-27.
36. Traxler, P., Allegrini, P. R., Brandt, R., Brueggen, J., Cozens, R., Fabbro, D., Grosios, K., Lane, H. A., McSheehy, P., Mestan, J. et al. (2004). AEE788: a dual family epidermal growth factor receptor/ErbB2 and vascular endothelial growth factor receptor tyrosine kinase inhibitor with antitumor and antiangiogenic activity. Cancer Res. 64, 4931-4941.
37. Utsuki, S., Sato, Y., Oka, H., Tsuchiya, B., Suzuki, S. and Fujii, K. (2002). Relationship between the expression of E-, N-cadherins and beta-catenin and tumor grade in astrocytomas. J. Neurooncol. 57, 187-192.
38. Wolf-Yadlin, A., Kumar, N., Zhang, Y., Hautaniemi, S., Zaman, M., Kim, H. D., Grantcharova, V., Lauffenburger, D. A. and White, F. M. (2006). Effects of HER2 overexpression on cell signaling networks governing proliferation and migration. Mol. Syst. Biol. 2, 54.
39. Yarden, Y. (2001). Biology of HER2 and its importance in breast cancer. Oncology 61 Suppl. 2, 1-13.